Associations between HLA-DRB1 alleles and leprosy in an Indonesian population

被引:0
|
作者
Soebono, H
Giphart, MJ
Schreuder, GMT
Klatser, PR
deVries, RRP
机构
[1] UNIV LEIDEN HOSP, DEPT IMMUNOHAEMATOL, NL-2300 RC LEIDEN, NETHERLANDS
[2] UNIV LEIDEN HOSP, BLOOD BANK, NL-2300 RC LEIDEN, NETHERLANDS
[3] GADJAH MADA UNIV, SCH MED, DEPT DERMATOL, YOGYAKARTA, INDONESIA
[4] ROYAL TROP INST, DEPT BIOMED RES, NL-1105 AZ AMSTERDAM, NETHERLANDS
关键词
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To investigate whether the susceptibility to leprosy (type), subclinical infection with Mycobacterium leprae and the antibody response against M. leprae-specific antigens are associated with HLA-DR phenotypes sequence-specific oligonucleotide HLA-DRB1 and DQA1 typing and antibody assays have been performed in 79 leprosy patients (41 TT/BT and 38 LL/BL) and 50 healthy controls from a Javanese population in Yogyakarta, Indonesia. DRB1*02 was associated with LL/BL [odds ratio (OR) 2.54, 95% confidence interval (CI) 0.97-9.78, p = 0.037 and attributable risk (AR) 41.5%] but not with TT/BT leprosy (p > 0.05). HLA-DRB1*12 was negatively associated with leprosy (either LL/BL or TT/BT [OR 0.33-0.35, p < 0.05, prevented fraction (PF) 58.8%-65.3%], No significant association was found between HLA-DRB1 or DQA1 type, anti-M. leprae antibody level and subclinical infection with M. leprae. These data indicate that in this population susceptibility to lepromatous leprosy is associated with HLA-DRB1*02, while resistance to leprosy is associated with HLA-DRB 1*12, These associations are not paralleled with associations of the same HLA types with anti-M. Leprae antibody level. Finally, the results of this study also support the notion that infection with M. leprae per se is not associated with HLA-DRB1 or DQA1 alleles.
引用
下载
收藏
页码:190 / 196
页数:7
相关论文
共 50 条
  • [1] Contribution of the HLA-DRB1 alleles in development of leprosy disease in an Argentinean population
    Borras, Garcia G.
    Regules, G.
    Gaspari, C.
    Cotorruelo, C.
    Biondi, C.
    Racca, L.
    Bottasso, O.
    Racca, A.
    VOX SANGUINIS, 2008, 95 : 182 - 183
  • [2] HLA-DRB1 alleles in a Macedonian population
    Spiroski, M
    HUMAN IMMUNOLOGY, 2004, 65 (9-10) : 1001 - 1002
  • [3] The HLA-DRB1 alleles and their associations with HIV infection
    Sochnevs, A
    Bekmane, U
    Eglite, E
    Sture, G
    Viksna, L
    Rozentale, B
    Shitova, O
    TISSUE ANTIGENS, 2002, 59 : 70 - 70
  • [4] Association of leprosy with HLA-DRB1 in an Argentinean population
    Borras, Silvia Garcia
    Cotorruelo, Carlos
    Racca, Liliana
    Recarte, Monica
    Garcias, Celeste
    Biondi, Claudia
    Bottasso, Oscar
    Racca, Amelia
    ANNALS OF CLINICAL BIOCHEMISTRY, 2008, 45 : 96 - 98
  • [5] Geographic patterns of functional categories of HLA-DRB1 alleles: a new approach to analyse associations between HLA-DRB1 and disease
    Gibert, M
    Sanchez-Mazas, A
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 2003, 30 (05): : 361 - 374
  • [6] HLA-DRB1 alleles in a population from Barcelona, Spain
    Morante, MP
    Moga, E
    Mosquera, AM
    Querol, S
    Garcia, J
    Rodriguez-Sanchez, JL
    Vidal, S
    HUMAN IMMUNOLOGY, 2004, 65 (9-10) : 1091 - 1093
  • [7] Identification of three novel HLA-DRB1 alleles, HLA-DRB1*07:150, HLA-DRB1*13:345 and HLA-DRB1*14:256
    Loginova, Maria
    Druzhinina, Svetlana
    Paramonov, Igor
    HLA, 2023, 102 (05) : 636 - 637
  • [8] Molecular, serological and genetic studies on two new HLA-DRB1 alleles - HLA-DRB1*0704 and HLA-DRB1*1507
    Darke, C
    Guttridge, MG
    Street, J
    Thompson, J
    Thomas, M
    TISSUE ANTIGENS, 2000, 56 (05): : 467 - 469
  • [9] Identification of two novel HLA-DRB1 alleles, HLA-DRB1*1214 and HLA-DRB1*1215, in two Taiwanese individuals
    Lee, H. L.
    Chu, C. C.
    Trejaut, J. A.
    Yang, K. L.
    Lin, M.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2008, 35 (06) : 423 - 426
  • [10] Characterisation of two novel HLA-DRB1 alleles, HLA-DRB1*04:01:24 and HLA-DRB1*13:353
    Loginova, Maria
    Obukhov, Ivan
    Paramonov, Igor
    HLA, 2024, 103 (05)